RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

IMS Health Incorporated

A collection of news and information related to IMS Health Incorporated published by this site and its partners.

Top IMS Health Incorporated Articles

Displaying items 12-22
  • Lawsuits pile up over popular birth control pills

    Lawsuits pile up over popular birth control pills
    Peotone's Maggie Yunker had been taking birth control pills for a year when her doctor suggested switching to a brand that also could clear up acne and ease some aggravating symptoms related to her period. Yunker was sold. But a year later, the 20-year-...
  • One in 10 Americans have taken drugs prescribed for others: poll

    One in 10 Americans have taken drugs prescribed for others: poll
    NEW YORK (Reuters) - Kurt is a 32-year-old IT systems administrator from Des Moines, Iowa. He has a colleague who had been prescribed "ridiculous amounts" of Vicodin for a chronic back problem. His colleague offered him some of the pills. Soon Kurt was...
  • New cancer tools allow patients to reconsider chemo

    New cancer tools allow patients to reconsider chemo
    LOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments. An approach to oncology that has been in place...
  • Lawmakers Take FDA to Task on Antidepressants

    Members of Congress on Thursday accused the Food and Drug Administration of suppressing information, for as long as eight years, about the increased risks of suicidal thought and behavior in children and teenagers taking antidepressants. "There is...
  • Diabetes cases hit record and half go undiagnosed

    Diabetes cases hit record and half go undiagnosed
    LONDON (Reuters) - Diabetes is running at record levels worldwide and half the people estimated to have the disease are, as yet, undiagnosed, according to a report on Wednesday. The number of people living with diabetes is now put at 371 million, up from...
  • Sleeping pill use grows as economy keeps people up at night

    Sleeping pill use grows as economy keeps people up at night
    Lost jobs and lost careers. Promising businesses in shambles. The college acceptance letter returned to its envelope. This is how President Obama recently described the effect of the tanking economy on ordinary Americans -- and the stresses keeping them...
  • Sleeping pills linked to higher risk of cancer, death, study says

    Sleeping pills linked to higher risk of cancer, death, study says
    A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem (Ambien), temazepam (Restoril), eszopiclone (Lunesta) and zaleplon (Sonata) are more likely to develop cancer, and far more likely to die...
  • Questions remain after judge lifts age limit on Plan B

    Questions remain after judge lifts age limit on Plan B
    With a federal judge clearing away age restrictions on purchasing emergency contraception, many Chicago-area health care providers, teens and others are preparing for more accessibility — even if they're not exactly sure how the drug will be made...
  • Janet Hughes, senior director of product marketing, Valence Health

    Janet Hughes, senior director of product marketing, Valence Health
    Chicago-based managed care provider Valence Health has named Janet Hughes senior director of product marketing. Prior to joining Valance Health, Hughes held senior consulting positions with organizations, including IMS Health and Accenture.
  • Walgreen withdraws earnings goals

    Walgreen withdraws earnings goals
    Walgreen Co. on Tuesday withdrew its profit goals for its 2016 fiscal year, citing unforeseen pressure in its pharmacy operations and a lack of clarity on the final structure it will take following its expected purchase of European drug giant Alliance...
  • Abbott to buy CFR Pharma for nearly $3 billion

    Abbott to buy CFR Pharma for nearly $3 billion
    One month after Abbott Laboratories Chief Executive Miles White told investors he was actively seeking to augment the company through acquisitions, the Lake County medical products giant said it will acquire Chilean generic pharmaceutical company CFR...